주식/증권 📈 긍정적 Jaguar Health targets mid-2027 MVID NDA filing with possible end-2027 U.S. approval, backed by up to 48% parenteral support reductions Seeking Alpha - Market News 2026/08/20 03:23:36 2회 원문 기사 보기